Changing patterns of presentations of patients with HIV-related disease at a tertiary referral centre and its implications for physician training

International Journal of STD and AIDS

Volumn 12, Issue 7, 2001, Pages 453-459

  Segal, R ^a   Poznansky, M C ^b   Connors, L ^a   Sands, K ^a   Barlam, T ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clinical presentations; HAART; HIV 1

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL FEATURE; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; OPPORTUNISTIC INFECTION; PATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL; RESIDENT; UNIVERSITY HOSPITAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIAL INFECTIONS; BOSTON; CLINICAL COMPETENCE; COHORT STUDIES; COMMUNITY HEALTH CENTERS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV-1; HUMANS; INTERNSHIP AND RESIDENCY; MALE; PATIENT ADMISSION; PHYSICIANS; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 0034934291     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011923480     Document Type: Article

References (40)

1. Characteristics of hospitalized patients following availability of HAART
2. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centers
3. Impact of HAART on rates and types of hospitalization at a New York City hospital
4. The impact of new antiretroviral therapy on HIV-associated hospital admissions and deaths
5. Stabilization of in-patient daily census despite continued reduction in HIV-related admissions at a New York City hospital
6. Tracking of hospital-based inpatient HIV/AIDS population demonstrates changing trends in patient care
7. Inpatient and outpatient hospitalization in Ontario for HIV/AIDS (1987-1995)
8. Changes in EEIV hospitalizations since the introduction of multidrug therapies at a local tertiary HIV referral centre - Impact on hospital and community resources
9. Changing epidemiology of hospital admissions among HIV+ patients
10. Protease inhibitors lead to a change of infectious diseases unit activity
11. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
12. Differences in the incidence rates of opportunistic processes before and after the availability of protease inhibitors
13. Clinical manifestations of HIV infections in the era of highly active antiretroviral treatment in France
14. Effect of antiretroviral therapy on clinical outcomes and cost in a university-based HIV/AIDS program: 1995-1997
15. Introduction of protease inhibitors results in decreasing incidence of oropharyngeal candidiasis in an HIV patient cohort study
16. Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a veterans administration hospital
17. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
18. The care of HIV-infected adults in the United States
19. Bacterial pneumonia in HIV-infected patients
20. Bacterial diseases in 2718 hospitalized HIV-patients
21. Bacteremia in hospitalized patients infected with human immunodeficiency virus: A case-control study of risk factors and outcome
22. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: A clinical, radiological, microbiological and epidemiological study
23. Community-acquired bacteremia in HIV-infected patients
24. Decreases in HIV-related morbidity, mortality, and health care utilization related to highly active antiretroviral therapy (HAART)
25. Effect of highly aggressive antiretroviral therapy on the incidence of bacteremia in HIV+ patients
26. Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care
27. Effect of trimethoprim-sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis on bacterial illness, Pneumocystis carinii pneumonia and death in persons with AIDS
28. HIV-associated pneumonias: The efficacy of pneumococcal vaccine
29. Antibody to capsular polysaccharides of streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine
30. Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease
31. The influence of human immunodeficiency virus infection on antibody response to influenza vaccines
32. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination
33. Influenza vaccination of human immunodeficiency virus-infected adults: Impact on plasma levels of HIV type 1 RNA and determinants of antibody response
34. Effect of influenza vaccination on viral loads in HIV patients
35. Induction of HIV-1 replication by influenza vaccination in patients on potent antiretroviral therapy
36. Efficacy of influenza vaccination in HIV-infected persons
37. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy
38. Managing resistance to anti-HIV drugs: An important consideration for effective disease management
39. Clinical progression and virological failure on HAART in HIV-1 patients
40. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients survival